NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

Ramshackle would be one word to sum up DCVax Phase 3.

NWBO has used more bubblegum and duct tape on this thing to keep it going than the Soviets and Russians used on the Mir Space Station.

But like the Mir, I am afraid that this project cannot be kept in orbit forever.

It is now perfectly obvious that the screening halt by FDA was not a good thing for NWBO shareholders.

If we slip our September deadline to finish the trial that will be the icing on Miss Havisham's Wedding Cake.

So while I think with Buzdargate you hurt shareholders a lot by giving NWBO management and its apologists an excuse for not communicating with us at all, you were probably right about NWBO's prospects.

This Phase 3 trial seems to prove your rule that companies below a certain market cap almost invariably fail Phase 3 Trials.

Now why that is could still be open to debate.

Maybe the science behind DCVax is fundamentally flawed and the its low market cap and inability to attract enough capital to build a cash runway is a symptom of that.

Maybe DCVax has some potential but NWBO's chronic penury and negative press make it impossible for the company to design and sustain a Phase 3 trial that will pass muster with the FDA. If so then you and people like you can and do create a self-fulfilling prophecy by making it harder for them to generate investor interest.

In any case, And I know other people thought this before, this uncertainty cannot last much longer.